As of 2025-01-14, the EV/EBITDA ratio of Cipher Pharmaceuticals Inc (CPH.TO) is 32.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CPH.TO's latest enterprise value is 410.46 mil CAD. CPH.TO's TTM EBITDA according to its financial statements is 12.67 mil CAD. Dividing these 2 quantities gives us the above CPH.TO EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 12.2x | 11.4x |
| Forward P/E multiples | 4.5x - 11.7x | 8.1x |
| Fair Price | 1.10 - 6.98 | 4.90 |
| Upside | -92.3% - -51.1% | -65.7% |
| Date | EV/EBITDA |
| 2025-01-07 | 22.97 |
| 2025-01-06 | 22.96 |
| 2025-01-03 | 22.67 |
| 2025-01-02 | 22.51 |
| 2024-12-31 | 22.53 |
| 2024-12-30 | 22.50 |
| 2024-12-27 | 22.60 |
| 2024-12-24 | 23.11 |
| 2024-12-23 | 23.00 |
| 2024-12-20 | 23.04 |
| 2024-12-19 | 22.72 |
| 2024-12-18 | 22.13 |
| 2024-12-17 | 22.58 |
| 2024-12-16 | 22.08 |
| 2024-12-13 | 22.41 |
| 2024-12-12 | 22.09 |
| 2024-12-11 | 23.30 |
| 2024-12-10 | 23.37 |
| 2024-12-09 | 24.40 |
| 2024-12-06 | 24.88 |
| 2024-12-05 | 24.53 |
| 2024-12-04 | 24.54 |
| 2024-12-03 | 24.32 |
| 2024-12-02 | 23.89 |
| 2024-11-29 | 23.97 |
| 2024-11-28 | 23.46 |
| 2024-11-27 | 23.13 |
| 2024-11-26 | 22.64 |
| 2024-11-25 | 22.41 |
| 2024-11-22 | 23.28 |
| 2024-11-21 | 22.86 |
| 2024-11-20 | 23.09 |
| 2024-11-19 | 22.99 |
| 2024-11-18 | 22.78 |
| 2024-11-15 | 21.62 |
| 2024-11-14 | 21.80 |
| 2024-11-13 | 20.27 |
| 2024-11-12 | 20.40 |
| 2024-11-11 | 20.38 |
| 2024-11-08 | 21.91 |
| 2024-11-07 | 24.24 |
| 2024-11-06 | 23.53 |
| 2024-11-05 | 23.13 |
| 2024-11-04 | 23.63 |
| 2024-11-01 | 23.82 |
| 2024-10-31 | 23.53 |
| 2024-10-30 | 24.25 |
| 2024-10-29 | 24.46 |
| 2024-10-28 | 24.73 |
| 2024-10-25 | 25.61 |